<DOC>
	<DOC>NCT00311350</DOC>
	<brief_summary>This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.</brief_summary>
	<brief_title>Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Healthy men and women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Health</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>ileus</keyword>
</DOC>